MEP90608A - Postupak za spravljanje smješa - Google Patents

Postupak za spravljanje smješa

Info

Publication number
MEP90608A
MEP90608A MEP-906/08A MEP90608A MEP90608A ME P90608 A MEP90608 A ME P90608A ME P90608 A MEP90608 A ME P90608A ME P90608 A MEP90608 A ME P90608A
Authority
ME
Montenegro
Prior art keywords
preparing
dispersions
solution
relates
compositions
Prior art date
Application number
MEP-906/08A
Other languages
English (en)
Inventor
Patrick Busson
Marco Schroeder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP90608(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ME00672B publication Critical patent/ME00672B/me
Publication of MEP90608A publication Critical patent/MEP90608A/bs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Ovaj pronalazak se odnosi na postupak za spravljanje smješa, prvenstveno farmaceutskih smješa iz rastvora ili disperzija, u obliku ekspandiranih, mehaničkih, lamelarnih, poroznih, nalik na sunđer ili pjenasti h struktura. Ovaj postupak obuhvata faze: a) pripremanje rastvora ili homogene disperzije tečnosti i jedinjenja izabranog iz grupe koja se sastoji od jednog ili više farmaceutskih akti vnih jedinjenja, jedne ili više farmaceutski pogodnih internih supstanci, i njihova smješa, koja prati b) ekspandovanje rastvora ili homogene disperzije bez ključanja. Izum se takođe odnosi na smješe, njihovu dalju obradu i sve odgovarajuće oblike doziranja koji se mogu dobiti navedenim postupkom.
MEP-906/08A 2000-06-27 2001-06-18 Postupak za spravljanje smješa MEP90608A (bs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00113535 2000-06-27
PCT/EP2001/006834 WO2002000201A2 (en) 2000-06-27 2001-06-18 Method for preparing a composition

Publications (2)

Publication Number Publication Date
ME00672B ME00672B (me) 2011-12-20
MEP90608A true MEP90608A (bs) 2011-12-20

Family

ID=8169074

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-906/08A MEP90608A (bs) 2000-06-27 2001-06-18 Postupak za spravljanje smješa

Country Status (38)

Country Link
US (3) US6534087B2 (bs)
EP (1) EP1296656B1 (bs)
JP (2) JP4149803B2 (bs)
KR (1) KR100557845B1 (bs)
CN (1) CN1236764C (bs)
AR (1) AR029278A1 (bs)
AT (1) ATE334662T1 (bs)
AU (2) AU2001281846B2 (bs)
BR (1) BRPI0112014B1 (bs)
CA (1) CA2411153C (bs)
CY (1) CY1105714T1 (bs)
CZ (1) CZ301813B6 (bs)
DE (1) DE60121953T2 (bs)
DK (1) DK1296656T3 (bs)
EC (1) ECSP024401A (bs)
EG (1) EG24141A (bs)
ES (1) ES2269441T3 (bs)
HK (1) HK1058314A1 (bs)
HR (1) HRP20021009B1 (bs)
HU (1) HU229550B1 (bs)
IL (2) IL153282A0 (bs)
JO (1) JO2247B1 (bs)
MA (1) MA26922A1 (bs)
ME (1) MEP90608A (bs)
MX (1) MXPA02012583A (bs)
MY (1) MY129798A (bs)
NO (1) NO332181B1 (bs)
NZ (1) NZ523024A (bs)
PE (1) PE20020101A1 (bs)
PL (1) PL203804B1 (bs)
PT (1) PT1296656E (bs)
RU (1) RU2244542C2 (bs)
SI (1) SI1296656T1 (bs)
TW (1) TWI278325B (bs)
UY (1) UY26799A1 (bs)
WO (1) WO2002000201A2 (bs)
YU (1) YU96602A (bs)
ZA (1) ZA200209649B (bs)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
AU2001281846B2 (en) * 2000-06-27 2006-04-27 Cheplapharm Arzneimittel Gmbh Method for preparing a composition
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
CN1325050C (zh) 2002-04-26 2007-07-11 霍夫曼-拉罗奇有限公司 包含脂肪酶抑制剂和葡甘露聚糖的药物组合物
KR100517072B1 (ko) * 2002-11-25 2005-09-26 주식회사 태평양 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
CA2548892C (en) * 2003-12-12 2015-10-27 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
CA2562213A1 (en) * 2004-04-06 2005-11-24 Rpg Life Sciences Limited Mouth dissolvable and meltable, and water dispersable delivery formulation
JP4329816B2 (ja) * 2004-09-15 2009-09-09 萬有製薬株式会社 サンプリング方法、サンプリング装置、ｌｏｇＤ測定方法及びｌｏｇＤ測定システム
WO2006073333A2 (fr) * 2004-12-31 2006-07-13 Mikhail Yurievich Gotovsky Preparations de resonance magnetique, et dispositif permettant de selectionner individuellement de telles preparations afin d'augmenter l'activite d'un organisme dans des conditions environnementales actuelles
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium
WO2006110809A2 (en) * 2005-04-12 2006-10-19 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
US20070060610A1 (en) * 2005-06-16 2007-03-15 Wempe Michael F Methods and pharmaceutical formulations for increasing bioavailability
WO2006136197A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
US10010494B2 (en) 2005-10-19 2018-07-03 Menni Menashe Zinger Methods for the treatment of hyperhidrosis
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
RU2008137613A (ru) 2006-02-20 2010-03-27 Тугаи Сейяку Кабусики Кайся (Jp) Фармацевтическая композиция, содержащая озельтамивира фосфат
EP2002201A2 (en) 2006-03-16 2008-12-17 Duke University Methods, systems, and computer program products for performing real-time quadrature projection based fourier domain optical coherence tomography
CN1820744B (zh) 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
EP1872777A1 (en) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising tetrahydrolipstatin
KR100812824B1 (ko) 2006-09-27 2008-03-12 주식회사 제닉 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름
US8460726B2 (en) 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
TW200902091A (en) * 2007-05-18 2009-01-16 Tti Ellebeau Inc Systems, devices, and methods for passive transdermal delivery of active agents to a biological interface
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
EP2219614A1 (en) * 2007-10-15 2010-08-25 Inventis DDS Pvt Limited Pharmaceutical composition of orlistat
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
GB0900551D0 (en) * 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation
EP2410996B1 (en) 2009-03-27 2017-08-02 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
NZ597053A (en) 2009-05-26 2014-02-28 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
EP2482802A4 (en) * 2009-09-29 2013-08-07 Michael Burnet NEW PESTICIDE FORMULATIONS
KR100940745B1 (ko) * 2009-10-15 2010-02-04 광동제약 주식회사 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
KR101021030B1 (ko) * 2010-03-25 2011-03-09 엘지이노텍 주식회사 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체
NO2557151T3 (bs) * 2010-04-07 2018-03-03
LT2603100T (lt) 2010-08-13 2018-07-25 Advanced Bionutrition Corp. Stabilizuojanti kompozicija, skirta biologinių medžiagų sausam saugojimui
CN103228266B (zh) * 2010-10-29 2017-11-14 健康科学西部大学 三元混合物制剂
PL2680815T3 (pl) 2011-03-01 2017-02-28 The Procter & Gamble Company Porowate, ulegające rozpadowi stałe podłoże do zastosowań związanych z higieną osobistą
CN114601849A (zh) 2012-03-23 2022-06-10 先进生物营养公司 生物材料的稳定化组合物
CN103222964B (zh) * 2013-01-29 2014-10-08 青岛大学 一种奥利司他口服制剂及其制备方法
GB2524496A (en) * 2014-03-24 2015-09-30 British Airways Plc Dynamic tracking and control of passenger travel progress
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
EP3314007B1 (en) 2015-06-25 2024-01-24 Native Microbials, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
CA2994112C (en) 2015-07-29 2023-08-08 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
JP6778051B2 (ja) * 2016-08-18 2020-10-28 沢井製薬株式会社 オセルタミビルリン酸塩含有医薬組成物
CA3048246A1 (en) 2016-12-28 2018-07-05 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
US12018313B2 (en) 2016-12-28 2024-06-25 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles
WO2019069108A1 (en) * 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
US4489438A (en) * 1982-02-01 1984-12-18 National Data Corporation Audio response system
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
ATE216577T1 (de) 1992-01-29 2002-05-15 Takeda Chemical Industries Ltd Schnellösliche tablette und ihre herstellung
US5560921A (en) 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
JP3722294B2 (ja) * 1993-02-23 2005-11-30 ワーナー−ランバート・コンパニー 実質的にアルコールを含有しない医薬組成物の製造方法
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5536264A (en) * 1993-10-22 1996-07-16 The Procter & Gamble Company Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
HU229200B1 (en) 1995-02-27 2013-09-30 Gilead Sciences Inc Selective inhibitors of viral or bacterial neuraminidase
AU720933B2 (en) 1995-02-27 2000-06-15 Gilead Sciences, Inc. Novel selective inhibitors of viral or bacterial neuraminidases
EP0831790B1 (en) * 1995-06-07 2003-05-07 Elan Drug Delivery Limited Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
EP0893992B1 (en) * 1996-04-16 2004-03-03 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
ID21571A (id) * 1996-10-14 1999-06-24 Hoffmann La Roche Proses pembuatan preparasi bubuk
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JPH11137208A (ja) 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
CN1148169C (zh) * 1998-04-09 2004-05-05 弗·哈夫曼-拉罗切有限公司 通过溶于压缩气体和表面活性剂制备(亚)微米级粒子的方法
PT1105122E (pt) 1998-08-14 2005-08-31 Hoffmann La Roche Composicoes farmaceuticas que contem inibidores de lipase
BR9912979B1 (pt) 1998-08-14 2010-09-21 composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
ATE400252T1 (de) 1999-02-10 2008-07-15 Pfizer Prod Inc Pharmazeutische feste dispersionen
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
AU2001281846B2 (en) * 2000-06-27 2006-04-27 Cheplapharm Arzneimittel Gmbh Method for preparing a composition

Also Published As

Publication number Publication date
US7074431B2 (en) 2006-07-11
JP2007302683A (ja) 2007-11-22
KR100557845B1 (ko) 2006-03-10
ZA200209649B (en) 2004-03-10
NO20026197D0 (no) 2002-12-23
ECSP024401A (es) 2003-02-06
HU229550B1 (en) 2014-01-28
AU8184601A (en) 2002-01-08
CA2411153A1 (en) 2002-01-03
RU2244542C2 (ru) 2005-01-20
PT1296656E (pt) 2006-12-29
DE60121953D1 (de) 2006-09-14
TWI278325B (en) 2007-04-11
BRPI0112014B1 (pt) 2016-09-13
CZ2003212A3 (cs) 2003-06-18
EG24141A (en) 2008-08-06
HK1058314A1 (en) 2004-05-14
JP2004501184A (ja) 2004-01-15
CA2411153C (en) 2007-01-30
UY26799A1 (es) 2001-12-28
EP1296656A2 (en) 2003-04-02
US20060134205A1 (en) 2006-06-22
WO2002000201A2 (en) 2002-01-03
US6534087B2 (en) 2003-03-18
JP4149803B2 (ja) 2008-09-17
IL153282A (en) 2008-03-20
YU96602A (sh) 2005-03-15
CN1236764C (zh) 2006-01-18
CY1105714T1 (el) 2010-12-22
NZ523024A (en) 2004-08-27
ATE334662T1 (de) 2006-08-15
ME00672B (me) 2011-12-20
DE60121953T2 (de) 2007-03-08
PE20020101A1 (es) 2002-02-12
BR0112014A (pt) 2003-05-13
HUP0302060A2 (hu) 2003-09-29
PL365803A1 (en) 2005-01-10
US20030039614A1 (en) 2003-02-27
PL203804B1 (pl) 2009-11-30
MY129798A (en) 2007-04-30
HRP20021009B1 (en) 2011-07-31
CN1438880A (zh) 2003-08-27
NO332181B1 (no) 2012-07-16
IL153282A0 (en) 2003-07-06
KR20030023880A (ko) 2003-03-20
MA26922A1 (fr) 2004-12-20
ES2269441T3 (es) 2007-04-01
US20020018812A1 (en) 2002-02-14
HRP20021009A2 (en) 2004-02-29
DK1296656T3 (da) 2006-11-27
AR029278A1 (es) 2003-06-18
HUP0302060A3 (en) 2006-07-28
NO20026197L (no) 2002-12-23
AU2001281846B2 (en) 2006-04-27
SI1296656T1 (sl) 2006-12-31
EP1296656B1 (en) 2006-08-02
WO2002000201A3 (en) 2002-04-18
MXPA02012583A (es) 2003-04-10
JO2247B1 (en) 2004-10-07
CZ301813B6 (cs) 2010-06-30

Similar Documents

Publication Publication Date Title
MEP90608A (bs) Postupak za spravljanje smješa
BRPI0408681A (pt) compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
BR0214279A (pt) Composições farmacêuticas em forma particulada
ATE232087T1 (de) Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
WO2006003481A3 (en) Oleaginous pharmaceutical and cosmetic foam
CA2268927A1 (en) Aqueous-based pharmaceutical composition
EA200900733A1 (ru) ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И БОЛЕЗНЕЙ, СВЯЗАННЫХ С АНГИОГЕНЕЗОМ
GB2395902A (en) Spontaneous emulsions containing cyclosporine
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
MY143795A (en) Tetrahydropyridoindole derivatives
BR0214431A (pt) Preparação de extrato de gengibre estável, processo para produção da mesma, preparação galênica, e, uso de uma preparação de extrato de gengibre estabilizada e de uma preparação galênica
ATE424816T1 (de) Zubereitungen für die topische anwendung und verfahren zur abgabe eines wirkstoffs an ein substrat
IS7311A (is) Lyfjafræðileg samsetning sem samanstendur af sýklósporíni og notkun á henni
BR0316724A (pt) Compostos, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas
TNSN03065A1 (en) BIOPESTICIDE COMPOSITIONS
JP2003525895A5 (bs)
HUP0301377A2 (hu) Tiotropiumsót tartalmazó inhalációs oldatformájú kombinációs gyógyszerkészítmény
WO2002003973A3 (en) Compositions comprising isosorbide dinitrate and methods for treatment of anal fissure
CN104666245B (zh) 一种缓释性松油烯‑4‑醇微乳及其制备方法
NO20060456L (no) Ren D-(17a)-13-etyl-17-hydroksy-18,19-dinorpregn-4-en-20-yn-3-on-3E og 3Z-oksimisomerer, samt fremgangsmater for syntesene av blandingen av isomerer og de rene isomerene
MX2008010927A (es) Antagonistas del receptor 5 de quimiocinas cc utiles para el tratamiento del virus de inmunodeficiencia humana.
KR101920367B1 (ko) 계피 및 희토를 이용한 물티슈의 제조방법 및 이에 의해 제조된 물티슈
JPH0723283B2 (ja) 農薬又は防疫薬粒剤用溶出助剤
BRPI0403668B8 (pt) composições farmacêuticas de desintegração oral com altas concentrações de aspartame